DataMeds AI, Inc (MEDS) vs Scienture Holdings, Inc. (SCNX)

DataMeds AI, Inc and Scienture Holdings, Inc. are both Pharmaceutical Retailers companies. Scienture Holdings, Inc. is the larger, with a market value of $12.3M against $10.9M — 1.1× the size. Scienture Holdings, Inc. grew revenue faster over the last twelve months: 458.7% against −78.2%. DataMeds AI, Inc has the higher net margin (−1,100.3% vs −4,621.0%) and the higher return on invested capital (0.00% vs −38.3%). Across the 16 metrics below, DataMeds AI, Inc leads on 9 and Scienture Holdings, Inc. on 7.

Valuation

Metric MEDS SCNX Pharmaceutical Retailers median
P/E n/m n/m —
P/S 1.00 13.51 0.47
P/B n/m 0.17 —
Price to free cash flow n/m n/m —
EV/EBITDA n/m n/m —
EV/Sales 3.15 15.83 0.56
Earnings yield (1,483.28%) (750.00%) (90.20%)
Free cash flow yield (183.08%) (153.30%) (49.52%)

Profitability

Metric MEDS SCNX Pharmaceutical Retailers median
Gross margin (90.64%) 87.73% 26.10%
Operating margin (875.73%) (4,878.95%) (73.45%)
Net margin (1,100.29%) (4,621.02%) (94.59%)
Free cash flow margin (182.72%) (1,758.26%) (29.37%)
Return on equity 949.27% (53.47%) (53.47%)
Return on assets (202.97%) (39.53%) (35.12%)
Return on invested capital 0.00% (38.25%) (19.45%)

Growth

Metric MEDS SCNX Pharmaceutical Retailers median
Revenue growth (TTM) (78.16%) 458.71% 91.60%
EPS growth (last fiscal year) (853.33%) (208.87%) —
Revenue growth, 5-year CAGR — (52.10%) 3.34%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MEDS SCNX Pharmaceutical Retailers median
Debt to equity (1.01) 0.15 0.01
Current ratio 0.14 3.04 1.35
Net debt to EBITDA (0.30) 0.17 0.17

Dividend

Metric MEDS SCNX Pharmaceutical Retailers median
Dividend yield — — —
Payout ratio — 0.00 0.00

Size

Metric MEDS SCNX Pharmaceutical Retailers median
Market cap 10.92m 12.29m 9.36m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack